Physician profile
Ryan Vazales
NPI 1043624372
$336,603.33
in general payments reported to CMS, 2019-2025
11 companies · $284K in 2025
The $284K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,512 · 2020: $455 · 2021: $9,924 · 2022: $16K · 2023: $13K · 2024: $9,355 · 2025: $284K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $274K · Consulting Fee: $27K · Travel and Lodging: $5,167 · Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $273,500.00 |
| Consulting Fee | $27,300.00 |
| Travel and Lodging | $5,167.08 |
| Food and Beverage | $540.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $273,500.00 | 2025 | |
| Orthofix Medical, INC. | $54,532.87 | 2019-2025 | Truelok, Truelok System, Galaxy Fixation System |
| Fortis Surgical, LLC | $3,832.24 | 2019-2022 | |
| Stryker Corporation | $2,541.52 | 2019-2022 | |
| Arteriocyte Medical Systems, INC. | $1,503.29 | 2019-2022 | |
| Smith+Nephew, INC. | $248.29 | 2019-2021 | |
| Integra Lifesciences Corporation | $119.99 | 2019 | |
| Anika Therapeutics, INC. | $105.91 | 2022 | |
| Access Pro Medical, LLC | $87.18 | 2025 | Matriderm |
| Kci USA, INC. | $71.18 | 2020 | |
| In2bones USA, LLC | $60.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Vazales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.